Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Skin Cancer01:30

Skin Cancer

5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

931
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
931
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

201
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy.

Nature biomedical engineering·2026
Same author

Sociodemographic and clinical characteristics of patients with Kaposi sarcoma: Characterization of early-onset disease in a serial cross-sectional study, 2010-2022.

Journal of the American Academy of Dermatology·2026
Same author

Atypical ulcers in the inpatient setting evaluated by special consult services.

Journal of wound care·2026
Same author

Supportive care and dermatologic management of Mpox.

Current opinion in HIV and AIDS·2026
Same author

Immune-Related Dermatological Conditions Among Refugee and Migrant Populations.

International journal of dermatology·2026
Same author

Geographical distribution of clinical studies for melanoma: A retrospective analysis of accessibility.

Journal of the American Academy of Dermatology·2025

Related Experiment Video

Updated: Jan 16, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K

Updates on Kaposi sarcoma.

Kyaw Zin Htet1, Eman Bahrani2, Kieron S Leslie3

  • 1Tulane University School of Medicine, New Orleans, Louisiana, USA.

Clinics in Dermatology
|September 26, 2025
PubMed
Summary
This summary is machine-generated.

Kaposi sarcoma (KS) is a vascular tumor linked to human herpesvirus 8. This review covers KS clinical features, diagnosis, and treatment across its diverse forms.

More Related Videos

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.3K
Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

792

Related Experiment Videos

Last Updated: Jan 16, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.3K
Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

792

Area of Science:

  • Oncology
  • Dermatology
  • Infectious Diseases

Background:

  • Kaposi sarcoma (KS) is an angioproliferative tumor associated with human herpesvirus 8 (HHV-8).
  • KS was first described in 1872, affecting the skin of elderly men, and is now known in four clinical categories: classic, endemic, epidemic (AIDS-related), and iatrogenic.
  • The diverse clinical presentations, epidemiology, and complications necessitate a comprehensive understanding.

Purpose of the Study:

  • To summarize the clinical features, diagnostic modalities, and therapeutic regimens for all types of Kaposi sarcoma.
  • To highlight the importance of prompt recognition and multidisciplinary management of KS.
  • To briefly mention ongoing research into newer, pathogenesis-based targeted therapies.

Main Methods:

  • This is a review article, synthesizing existing knowledge on Kaposi sarcoma.
  • Information was gathered from historical documentation and current medical literature.
  • The review categorizes KS and discusses its various aspects.

Main Results:

  • Kaposi sarcoma presents heterogeneously across its four main clinical categories.
  • Effective management requires prompt recognition and a multidisciplinary approach.
  • New targeted therapies are under investigation.

Conclusions:

  • Kaposi sarcoma is a complex vascular tumor requiring a comprehensive clinical approach.
  • Multidisciplinary care is crucial for optimal patient outcomes.
  • Continued research into targeted therapies holds promise for future treatment strategies.